<SEC-DOCUMENT>0000950170-24-063689-index.html : 20240523
<SEC-HEADER>0000950170-24-063689.hdr.sgml : 20240523
<ACCEPTANCE-DATETIME>20240522190623
ACCESSION NUMBER:		0000950170-24-063689
CONFORMED SUBMISSION TYPE:	S-8 POS
PUBLIC DOCUMENT COUNT:		6
FILED AS OF DATE:		20240523
DATE AS OF CHANGE:		20240522
EFFECTIVENESS DATE:		20240523

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Viking Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001607678
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				461073877
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-8 POS
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-236666
		FILM NUMBER:		24974848

	BUSINESS ADDRESS:	
		STREET 1:		9920 PACIFIC HEIGHTS BLVD, SUITE 350
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-704-4660

	MAIL ADDRESS:	
		STREET 1:		9920 PACIFIC HEIGHTS BLVD, SUITE 350
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-8 POS
<SEQUENCE>1
<FILENAME>vktx-form_s-8_pos_333-23.htm
<DESCRIPTION>S-8 POS
<TEXT>
Document 1 - file: vktx-form_s-8_pos_333-23.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>vktx-ex5_1.htm
<DESCRIPTION>EX-5.1
<TEXT>
Document 2 - file: vktx-ex5_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>vktx-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
Document 3 - file: vktx-ex23_1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img246856755_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: img246856755_0.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img246856755_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 5 - file: img246856755_1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>img246856755_2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 6 - file: img246856755_2.jpg

</DOCUMENT>
</SEC-DOCUMENT>